SEARCH

SEARCH BY CITATION

References

  • 1
    McGeer P, Eccles JC, McGeer EG. Molecular neurobiology of the mammalian brain. Plenum Press, New York, 1987; pp. 344345.
  • 2
    Tan DX, Manchester LC, Burkardt S et al. N1acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 22942296.
  • 3
    Reiter RJ, Melchiorri D, Sewerynek E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 111.
  • 4
    Turjanski AG, Rosenstein RE, Estrin DA. Reaction of melatonin and related indoles with free radicals: a computational study. J Med Chem 1998; 41: 36843689.
  • 5
    Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Progr Neurobiol 1998; 56: 359384.
  • 6
    Tan DX, Manchester LC, Reiter RJ et al. Melatonin directly scavenges hydrogen peroxide: A potential new metabolic pathway of melatonin biotransformation. Free Rad Biol Med 2000; 29: 11771185.
  • 7
    Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J 1993; 1: 5760.
  • 8
    Tan DX, Poeggeler B, Reiter RJ et al. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993; 70: 6571.
  • 9
    Tan DX, Reiter RJ, Chen LD et al. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by carcinogen safrole. Carcinogenesis 1994; 15: 215218.
  • 10
    Vijayalaxmi, Reiter RJ, Herman TS et al. Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutat Res 1998; 397: 203208.
  • 11
    Tang L, Reiter RJ, Li ZX et al. Melatonin reduces the increase in 8-hydroxy-deoxyguanosine levels in the brain and liver of kainic acid-treated rats. Mol Cell Biochem 1998; 178: 299303.
  • 12
    Sewerynek E, Melchiorri D, Chen L et al. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radic Biol Med 1995; 19: 903909.
  • 13
    Li ZR, Reiter RJ, Fujimori O, et al. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin. J Pineal Res 1997; 22: 117123.
  • 14
    Melchiorri D, Reiter RJ, Attia AM et al. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995; 56: 8389.
  • 15
    Cohen G. Oxidative stress, mitochondrial respiration, and Parkinson's disease. Ann. NY Acad Sci 2000; 899112899120.
  • 16
    Brusco LI, Marquez M, Cardinali DP. Monozygotic twins with Alzheimer's disease treated with melatonin. Case report. J Pineal Res 1998; 25: 260263.
  • 17
    Smith MA., Perry G, Richey PL et al. Oxidative damage in Alzheimer's. Nature 1996; 382: 120121.
  • 18
    Brewer GJ. Neuronal plasticity and stressor toxicity during aging. Exp Gerontol 2000; 35: 11651183.
  • 19
    Zhang L, Zhao B, Yew DT et al. Processing of Alzheimer's amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells. Biochim Biophys Res Comm 1997; 235: 845848.
  • 20
    Li TK, Chen Ay, Yu C et al. Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Gene Dev 1999; 13: 15531560.
  • 21
    Cohen G, Farooqui R, Kesler N. Parkinson disease: new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 1997; 94: 48904894.
  • 22
    Acuna-Castroviejo D, Martin M, Macias M et al. Melatonin mitochondria and cellular bioenergetics. J Pineal Res 2001; 30: 6574.
  • 23
    Alberts B, Bray D, Lewis J et al. Molecular biology of the cell. Garland Publ Inc, New York, 1989; pp. 431433.
  • 24
    Betz AL. Oxygen free radicals and the brain microvasculature. In: The Blood-brain Barrier. Cellular and molecular biology. Partridge WM, ed., Raven Press, New York, 1993; pp. 303321.
  • 25
    Huang X, Atwood C S, Hartshorn et al. A The A-beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 76097616.
  • 26
    Miranda S, Opazo C, Larrondo LF et al. The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Progr Neurobiol 2000; 62: 633648.
  • 27
    Maurizi CP. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. Med Hypoth 2001; 57: 156160.
  • 28
    Lahiri DK. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types. J Pineal Res 1999; 26: 137146.
  • 29
    Chyan YJ, Poeggeler B, Omar RA et al. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 1999; 274: 2193721942.
  • 30
    Bozner P, Grishko V, LeDoux SP et al. The amyloid beta protein induces oxidative damage of mitochondrial DNA. J Neuropathol Exp Neurol 1997; 56: 13561362.
  • 31
    Daniels WM, van Rensburg SJ, van Zyl JM et al. Melatonin prevents beta-amyloid-induced lipid peroxidation. J Pineal Res 1998; 24: 7882.
  • 32
    Pappolla M, Bozner P, Soto C et al. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem 1998; 273: 71857188.
  • 33
    Pappolla MA, Simovich MJ, Bryant-Thomas T et al. The neuroprotective activities of melatonin against the Alzheimer b-protein are not mediated by melatonin membrane receptors. J Pineal Res 2002; 32: 135142.
  • 34
    Clapp-Lilly K L, Smith MA, Perry et al. G Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport 2001; 12: 12771280.
  • 35
    Clapp-Lilly KL, Smith MA, Perry G et al. Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices. Chem Biol Interact 2001; 134: 101107.
  • 36
    Ohyashiki T, Karino T, Matsui H. Stimulation of Fe(II)-induced lipid peroxidation in phosphatidylcholine liposome by aluminum at physiological pH. Biochim Biophys Acta 1993; 117: 182188.
  • 37
    Puget K, Michelson AM. Oxidation of luminol by xantine oxidase system in presence of carbonate anions. Photochem Photobiol 1976; 24: 499501.
  • 38
    Baudhuin P, Beaufay H, Rahman-Li Y et al. Intracellular distribution of monoamino oxidase, aspartate aminotransferase, alanina amino transferase, D-amino acid oxidase and catalase in rat liver tissue. Biochem J 1964; 92: 179184.
  • 39
    Wendel A. Glutathione peroxidase. Meth Enzymol 1981; 77: 325328.
  • 40
    Aldrich library of 13Cand, 1H FT NMR edition 1, vol.3, Aldrich USA, 1993.
  • 41
    Gitto E, Karbownik M, Reiter RJ et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001; 50: 756760.
  • 42
    Hardeland R, Reiter RJ, Poeggeler B et al. The significance of metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993; 17: 347357.
  • 43
    Savaskan E, Olivieri G, Brydon L et al. Cerebrovascular melatonin MT-1 receptor alterations in patients with Alzheimer's disease. Neurosci Lett 2001; 308: 912.
  • 44
    Halliwell B. Oxidant and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neuropathol Scand (Suppl) 1989; 1262312633.
  • 45
    Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 114.
  • 46
    Albarran MT, Lopez-Burillo S, Pablos MI et al. Endogenous rhythms of melatonin, total antioxidant status and superoxide dismutase activity in several tissues of chick and their inhibition by light. J Pineal Res 2001; 30: 227232.
  • 47
    Agapito MT, Antolin Y, del Brio MT et al. Protective effect of melatonin against adryamicin toxicity. J Pineal Res 2001; 31: 2330.
  • 48
    Reiter JR, Tang L, Garcia JJ et al. Pharmacological action of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60: 22552271.
  • 49
    Olivieri G, Brack C, Muller-Spahn F et al. Mercury induces cell cytotoxicity and oxidative stress and increase beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J Neurochem 2000; 74: 231236.
  • 50
    Sayre LM, Perry G, Harris PLR et al. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease a central role for bound transition metals. J Neurochem 2000; 74: 270279.
  • 51
    Wetterberg L. Melatonin and clinical application. Reproduction Nutr Dev 1999; 39: 367382.